Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare REITs Industry Analysis

UpdatedJul 27, 2026
DataAggregated Company Financials
Companies18
  • 7D3.2%
  • 3M18.6%
  • 1Y42.9%
  • YTDn/a

The Healthcare REITs industry is up 3.2% in the last week, with Welltower up 3.6%. This takes the industry's 12 month performance to a gain of 43%. Looking forward, earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the U.S. Healthcare REITs Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 27 Jul 2026US$325.3bUS$34.5bUS$1.6b36.1x206.1x9.4x
Wed, 24 Jun 2026US$277.7bUS$34.7bUS$1.6b37.9x171.9x8x
Fri, 22 May 2026US$289.6bUS$34.7bUS$1.6b39x179.2x8.4x
Sun, 19 Apr 2026US$275.4bUS$33.1bUS$361.5m42.8x761.8x8.3x
Tue, 17 Mar 2026US$265.7bUS$32.5bUS$355.1m37.4x748x8.2x
Thu, 12 Feb 2026US$259.3bUS$32.7b-US$426,906,000.0036x-607.3x7.9x
Sat, 10 Jan 2026US$239.8bUS$31.5bUS$440.3m32.4x544.6x7.6x
Mon, 08 Dec 2025US$254.2bUS$31.5bUS$440.3m32.2x577.3x8.1x
Wed, 05 Nov 2025US$234.3bUS$31.8bUS$391.0m29.8x599.3x7.4x
Fri, 03 Oct 2025US$232.6bUS$30.4bUS$354.3m32.1x656.5x7.6x
Sun, 31 Aug 2025US$222.1bUS$30.4bUS$332.7m34.8x667.6x7.3x
Tue, 29 Jul 2025US$209.0bUS$29.4b-US$197,911,000.0033.3x-1055.9x7.1x
Thu, 26 Jun 2025US$200.8bUS$29.4bUS$68.9m36.2x2914.1x6.8x
Sat, 24 May 2025US$192.6bUS$29.7bUS$181.8m31.7x1059x6.5x
Mon, 21 Apr 2025US$197.3bUS$28.7b-US$1,068,162,000.0034.3x-184.7x6.9x
Wed, 19 Mar 2025US$204.8bUS$28.7b-US$1,068,162,000.0035.9x-191.7x7.1x
Fri, 14 Feb 2025US$191.5bUS$28.2b-US$1,397,179,000.0040.2x-137.1x6.8x
Sun, 12 Jan 2025US$172.7bUS$27.4b-US$1,625,663,000.0040.4x-106.2x6.3x
Tue, 10 Dec 2024US$185.0bUS$27.4b-US$1,625,663,000.0043.3x-113.8x6.8x
Thu, 07 Nov 2024US$191.8bUS$27.0b-US$818,734,000.0047.8x-234.2x7.1x
Sat, 05 Oct 2024US$183.6bUS$26.2b-US$1,429,354,000.0054x-128.4x7x
Mon, 02 Sep 2024US$177.6bUS$26.2b-US$1,429,354,000.0052.5x-124.3x6.8x
Wed, 31 Jul 2024US$165.4bUS$26.4b-US$979,140,000.0049.4x-168.9x6.3x
Fri, 28 Jun 2024US$150.4bUS$26.1b-US$1,195,454,000.0043.4x-125.8x5.8x
Sun, 26 May 2024US$127.4bUS$23.1b-US$1,239,464,000.0037.6x-102.8x5.5x
Tue, 23 Apr 2024US$116.7bUS$22.6b-US$276,709,000.0041.9x-421.7x5.2x
Thu, 21 Mar 2024US$115.9bUS$22.5b-US$241,386,000.0041x-480x5.1x
Sat, 17 Feb 2024US$116.6bUS$23.3bUS$226.8m35.4x514.2x5x
Mon, 15 Jan 2024US$119.0bUS$24.3bUS$48.6m47.7x2449.1x4.9x
Wed, 13 Dec 2023US$114.5bUS$24.3bUS$48.6m42.7x2357x4.7x
Fri, 10 Nov 2023US$109.9bUS$24.3bUS$19.9m36.6x5526.6x4.5x
Sun, 08 Oct 2023US$104.1bUS$23.9bUS$463.1m30.7x224.7x4.3x
Tue, 05 Sep 2023US$111.2bUS$24.0bUS$472.6m33.7x235.2x4.6x
Thu, 03 Aug 2023US$116.6bUS$23.6bUS$734.2m33.9x158.9x4.9x
Price to Earnings Ratio

158.9x


Total Market Cap: US$116.6bTotal Earnings: US$734.2mTotal Revenue: US$23.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare REITs Industry Price to Earnings3Y Average 374.1x202420252026
Current Industry PE
  • Investors are pessimistic on the American Health Care REITs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 206x which is lower than its 3-year average PE of 374x.
  • The 3-year average PS ratio of 6.5x is lower than the industry's current PS ratio of 9.4x.
Past Earnings Growth
  • The earnings for companies in the Health Care REITs industry have grown 31% per year over the last three years.
  • Revenues for these companies have grown 13% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Healthcare REITs compare with similar industries?

US Market-1.05%
Real Estate0.76%
REITS-0.95%
Healthcare REITs3.18%
Hotel and Resort REITs2.27%
Retail REITs-0.16%
Office REITs-0.20%
Residential REITs-0.59%
Specialized REITs-0.95%
Diversified REITs-0.95%
Industrial REITs-1.89%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
WELL WelltowerUS$252.073.0%
+US$5.1b		59.2%PB4.1x
VTR VentasUS$100.534.4%
+US$2.1b		54.1%PB3.7x
OHI Omega Healthcare InvestorsUS$51.724.3%
+US$637.3m		35.3%PB3x
SBRA Sabra Health Care REITUS$22.3611.8%
+US$595.2m		24.4%PB2x
JAN Janus LivingUS$31.414.1%
+US$265.3m		n/aPB3.1x

Latest News

OHI
US$51.72
Omega Healthcare Investors
7D
4.3%
1Y
35.3%
WELL
US$252.07
Welltower
7D
3.0%
1Y
59.2%
Seeking Alpha • 12h

Welltower Needs A Miracle To Justify This Price

Summary Welltower trades at an extreme premium, with a 41x forward AFFO multiple and implied cap rates below 3%. WELL’s short-term AFFO per share growth is strong, but margin expansion and cost controls are unsustainable long-term. The REIT’s best move is to issue equity at these valuations, but future AFFO multiple compression poses significant downside risk. I expect WELL to underperform the REIT index over 5–10 years, as growth slows and valuation normalizes. Read the full article on Seeking Alpha
ARE
US$50.94
Alexandria Real Estate Equities
7D
1.8%
1Y
-35.6%
Seeking Alpha • Jul 24

Alexandria Real Estate: The Uncertainty Is Real, But The Discount Has Gone Too Far

Summary Alexandria Real Estate Equities, Inc. faces severe leasing headwinds, especially from public biotech tenants, driving market pessimism and a >30% stock decline since mid-2025. ARE trades at a steep discount—P/FFO ~7x and P/B 0.5x—reflecting deep uncertainty, but its high-quality, irreplicable assets and strong tenant relationships remain valuable. Balance sheet strength is evident: $28.8B in real estate, $400M cash, and $12.5B debt. Also, the 2026 FFO guidance is $6.30–$6.50 per share. Despite ongoing sector challenges and low visibility, I rate ARE stock a Buy, as even a 'less bad' quarter could trigger sentiment recovery given the low expectations. Read the full article on Seeking Alpha
AHR
US$57.44
American Healthcare REIT
7D
1.4%
1Y
55.2%
DOC
US$22.27
Healthpeak Properties
7D
-0.09%
1Y
29.0%
Narrative Update • Jul 24

DOC: Brookfield Venture And Index Additions Will Support Future Upside

Analysts have raised their price target on Healthpeak Properties to $27.22 from $26.94. This change reflects revised assumptions about fair value, discount rate, revenue growth, profit margins, and future P/E levels.
CTRE
US$43.25
CareTrust REIT
7D
1.9%
1Y
41.6%
SBRA
US$22.36
Sabra Health Care REIT
7D
11.8%
1Y
24.4%
VTR
US$100.53
Ventas
7D
4.4%
1Y
54.1%
Seeking Alpha • Jul 12

Ventas: Ahead Of Q2 Results, Lots To Like About This Senior-Care REIT

Summary Ventas is positioned as both a dividend and growth REIT, benefiting from macro tailwinds in senior housing demand. VTR’s investment-grade balance sheet, geographic diversity, and expanding portfolio underpin its resilience and modest growth outlook. Despite a rich 23x forward earnings multiple, upside forecasts are only 7%–10%, warranting a more neutral valuation stance. Dividend coverage is strong at 1.7x AFFO/share, with a 57% payout ratio and a focus on growth and safety over yield. Read the full article on Seeking Alpha
JAN
US$31.41
Janus Living
7D
4.1%
1Y
n/a